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Background: Persistent foramen ovale (PFO) is considered a cause of cryptogenic stroke and a risk factor for
neurological events in young patients. The reference standard for identifying a PFO is contrast-enhanced
transesophageal echocardiography (TEE).
The goal of this study was to evaluate the feasibility of transcranial color Doppler (TCD) and its diagnostic sensitivity
compared with TEE.
Methods: We investigated 420 patients admitted to our department with cryptogenic stroke, transient ischemic
attacks or other neurological symptoms. All patients underwent TCD and TEE evaluation. TCD and TEE examinations
were performed according to a standardized procedure: air-mixed saline was injected into the right antecubital vein
three times, while the Doppler signal was recorded during the Valsalva maneuver. During TCD the passage of
contrast into the right-middle cerebral artery was recorded 25 seconds following the Valsalva maneuver.
Results: We detected a right-to-left shunt in 220 patients (52.3%) and no-shunts in 159 patients (37.9%) with both
TCD and TEE. In 20 (4.8%) patients TEE did not reveal contrast passage which was then detected by TCD. In 21
(5.0%) patients only TEE revealed a PFO. The feasibility of both methods was 100%. TCD had a sensitivity of 95%
and a specificity of 92% in the diagnosis of PFO.
Conclusions: TCD has a relatively good sensitivity and specificity. TCD and TEE are complementary diagnostic tests
for PFO, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive
character, low cost and high feasibility.
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Persistent foramen ovale (PFO) is considered a cause of
cryptogenic stroke and a risk factor for neurological events
in patients under 40 years of age. PFO has been also associ-
ated with several disease processes such as arterial gas em-
bolism due to decompression, or platypnea-orthodeoxia
syndrome [1-4]. Although the clinical significance of PFO
in relation to cryptogenic stroke is still debated, identifica-
tion and assessment of this abnormality are nowadays a
routine diagnostic procedure.* Correspondence: moni_s@interia.pl
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unless otherwise stated.Agitated saline serum has been used in transthoracic
echocardiography (TTE), transesophageal echocardiog-
raphy (TEE) and transcranial color Doppler ultrasound
(TCD) for the detection of intracardiac shunts. The refer-
ence standard for identifying a PFO is contrast-enhanced
TEE but it is a semi-invasive, inconvenient and stressful
for the patients and also quite expensive procedure.
Some studies have analyzed the most suitable strategy
for the screening, diagnosis and quantification of PFO
[5-8]. The aim of this study was to evaluate the feasibil-
ity of transcranial Doppler and its diagnostic sensitivity
compared with transesophageal echocardiography.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic characteristics of the patients
Patients (n = 420)
Smoking 205 (48.8%)
Obesity 72 (17.4%)
Diabetes mellitus 19 (4.5%)
Hypertension 64 (15.2%)
Dyslipidemia 29 (6.9%)
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Patient population
We investigated 420 consecutive patients [(260 females,
160 males); mean age 34.8 ± 16.7 (13, 65) years] admit-
ted to our department with cryptogenic stroke, transient
ischaemic attacks (TIA) or other neurological symptoms
between 2007 and 2014. Most patients (over 50%) had a
history of TIA. The main demographic characteristics of
the patients are summarized in Table 1.
Protocol
All patients underwent TCD and TEE evaluation. The
studies were performed on the same day by two different
experienced cardiologists, unaware with respect to the re-
sult of the other study. The patients were examined in the
fasting state. Written informed consent was obtained from
all patients. The patients were in left lateral decubitus pos-
ition during both studies. The studies were performed at
resting state and during the Valsalva maneuver after con-
trast injection. The patients had been trained in perform-
ing the Valsalva maneuver before study. The training
phase included up to 5 Valsalva maneuver attempts, with
at least two resulting in septal shifting or reduced middle
cerebral artery flow velocity which was followed byFigure 1 Contrast TCD during the Valsalva maneuver. The middle cere
into the right middle cerebral artery (MCA).contrast injection and the Valsalva maneuver solicited.
The study was repeated at least three times.
Agitated saline contrast test
TCD and TEE examinations were performed according
to a standardized procedure. In brief, 10 mL of air-
mixed saline was injected into the right antecubital vein
at three different times, while the Doppler signal was re-
corded during the Valsalva maneuver. During TCD the
passage of contrast into the right-middle cerebral artery
was recorded 25 seconds after the Valsalva maneuver. A
mixture of 9 mL physiological saline and 1 mL air was
agitated 10 times in 2 10-mL syringes connected to a 3-
way stopcock to exchange the air-saline mix and achieve
good dilution. The bolus of saline solution was prepared
and injected by the same nurse using the same method
in all studies. The patients started the maneuver about
5 seconds after contrast injection, pressing against the
closed glottis for at least 10 seconds. They then per-
formed a deep expiration and inspiration, followed by a
deep expiration.
Transcranial doppler ultrasonography
A baseline TCD examination was performed with a
Toshiba Power Vision echo-machine using a 2-MHz
probe, according to standard practice guidelines. Middle
cerebral artery flow was monitored through the temporal
bone window. The middle cerebral artery was identified
with color Doppler in its proximal portion and insonated
bilaterally (Figure 1). On TCD study, the effectiveness of
the Valsalva maneuver was verified by a reduction of the
middle cerebral artery flow velocity, in comparison with
the basal spectrum. TCD was considered positive if atbral artery was identified with color Doppler. The passage of contrast
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spectrum within 25 seconds from contrast injection. The
shunt was defined as small (1, 10 microembolic signals),
medium (>10 microembolic signals), or large (>10 micro-
embolic signals with “curtain”).
Transesophageal echocardiography
The patients received local pharyngeal anesthesia with
10% topical lidocaine for TEE study. A TEE study was
performed using a Toshiba Power Vision machine with a
5.0-MHz multiplane probe, according to a standard
protocol including color flow Doppler data. The atrial
septum was analyzed from the transverse mid-esophageal
four-chamber view to the longitudinal biatrial-bicaval view
(Figure 2). Since PFO was not clearly recognized by a bica-
val view at 90° rotation, additional image planes (60°, 90°
and/or 110°-130°) were used to better analyze the atrial
septum. On TEE study, the effectiveness of the Valsalva
maneuver was verified by a reduction in right ventricular
and atrial size and by bulging of the atrial septum into the
left atrium. To assess PFO, semi-quantification of the right
to left shunt (RLS) was performed. On TEE the evaluation
was based on counting the number of micro bubbles
(MBs) moving from the right atrium to the left atrium
through the PFO after the Valsalva maneuver, within the
first three cardiac cycles. The studies were considered
positive for PFO when at least one micro bubble was ob-
served in the left atrium. The severity of the shunt was
quantified as mild (<10 micro bubbles), moderate (10–20
micro bubbles), or severe (>20). If the quantitative results
varied between the first and second study the largest num-
ber of MBs decided about the shunt size.Figure 2 Contrast TEE during the Valsalva maneuver. Contrast agent inStatistical analysis
The SPSS 13.0 software package was used for statistical
analysis. Quantitative data were expressed as the mean ±
standard deviation, qualitative data as the percentage. The
performance indexes used were sensitivity, specificity, pre-
dictive positive value (PPV), negative predictive value
(NPV), and k concordance index, which express the agree-
ment proportion beyond chance.
Sensitivity was defined as:
sentivity ¼ number of True Positives
number of True Positives þ number of False Negatives
Specificity was defined as:
specificity ¼ number of True Negatives
number of True Negatives þ number of False Positives
Results
Using both TCD and TEE, we detected a right-to-left
shunt in 220 patients (52.3%) and no-shunts in 159 pa-
tients (37.9%). In 20 (4.8%) patients TEE did not show
the passage of contrast which was later detected by
TCD. In 21 (5.0%) patients only TEE revealed a PFO.
The feasibility of both methods was 100%. Shunts con-
firmed by both methods (TCD and TEE) were found in:
78.4% of patients with cryptogenic stroke, in 48.6% of
patients with TIA, and only in 10.4% of patients with mi-
graine without aura (Table 2). Considering TEE as the
gold standard technique, TCD was able to identify 200
(91.3%) of the 241 patients with PFO. TCD showed a
NPV of 89%, PPV of 98%, sensitivity of 95%, and specifi-
city of 92%. TCD showed a high concordance (k = 0.89)the left atrium.
Table 2 Shunt grading using both transcranial doppler
ultrasonography and transesophageal echocardiography
SHUNT TEE (N= 220 pts –
TEE and
TCD positive)
TCD (N= 220 pts –
TEE and
TCD positive)
% of the same
grading using
both methods
Small 56 (25.5%) 70 (31.8%) 62.1
Medium 123 (55.9%) 119 (54.1%) 68.3
Large 41 (18.6%) 31 (14.1%) 83.2
TCD Transcranial Doppler Ultrasonography, TEE Transesophageal
Echocardiography.
Table 4 Sensitivity, specificity, negative predictive value,
and positive predictive value of transcranial doppler
ultrasonography in comparison with transesophageal
echocardiography in pfo detection
Technique PFO
(%)
PPV
(%)
NPV
(%)
Sensitivity
(%)
Specificity
(%)
Contrast-
enhanced TCD
90 98 89 95 92
NPV: Negative Predictive Value, PPV: Negative Predictive Value TCD: Transcranial
Doppler Ultrasonography, TEE: Transesophageal Echocardiography, PFO: Patent
Foramen Ovale.
Komar et al. Cardiovascular Ultrasound 2014, 12:16 Page 4 of 6
http://www.cardiovascularultrasound.com/content/12/1/16with TEE in PFO recognition (Table 3). Shunt grading in
both TCD and TEE methods was classified with the
same score in 70.5% of cases, and it was the highest in
the large shunt (Table 4).Discussion
Patent foramen ovale is a hemodynamically trivial intera-
trial communication that is present in about 25% of the
adult population. However, the clinical significance of
PFO in relation to cerebrovascular events is still debated,
identification and assessment of this abnormality are
nowadays a routine diagnostic procedure [6,9-12]. The
search for PFO is becoming more and more common in
young subjects suffering from migraine, TIA or crypto-
genic stroke [12-17]. At the moment there is no clearly
recognized standard protocol for performing both TEE
and TCD studies to identify PFO. For the first time, based
on the available literature, we developed a standardized
exercise protocol in both TEE and TCD studies.
Contrast transesophageal echocardiography is the gold
standard for the diagnosis of PFO, regardless of the fact
that this procedure is semi-invasive [18-24]. Therefore,
transcranial Doppler ultrasonography seems to be an at-
tractive alternative to TEE in the recognition of PFO, be-
cause it is a cheap and noninvasive examination [25-29].
The aim of this study was to evaluate the feasibility of
transcranial Doppler and its diagnostic sensitivity compared
with transesophageal echocardiography. Although the diag-
nostic power of TCD has been reported, only a few studiesTable 3 Identification of persistent for amen ovale using
both transcranial color doppler and transesophageal
echocardiography
Clinical characteristics
of patients
Identification of PFO
(both TCD and TEE)
Patients (n = 420) Patients (n = 220)
TIA 218 (51.9%) 106/218 (48.6%)
Migraine 67 (15.6%) 7/67 (10.4%)
Migraine with aura 50 (11.9%) 38/50 (76.0%)
Cryptogenic stroke 88 (20.9%) 69/88 (78.4%)
PFO Patent Foramen Ovale, TCD Transcranial Doppler Ultrasonography,
TEE Transesophageal Echocardiography, TIA Transient Ischaemic Attack.comparing both techniques (TCD and TEE) have been
published [5,30-33]. In our study TCD had a good sensitiv-
ity and specificity. In our opinion, in contrast to other in-
vestigators, TCD and TEE are complementary for PFO
diagnosis, but TCD should be recommended as the first
choice for screening because of its simplicity, non-invasive
character, low cost, and high feasibility. Contrary to other
researchers, our results and clinical experience show that
both methods are necessary and complementary to
recognize a significant foramen ovale.
The sensitivity and specificity of TCD for shunt detec-
tion vary in different studies according to both protocol
and diagnostic criteria [25-33]. In our study TCD had
89% NPV, 98% PPV, 95% sensitivity, and 92% specificity.
In the Caputi study a general concordance of up to 90%
between TEE and TCD was found. TCD sensitivity and
specificity were 96.8% and 78.4%, respectively [25].
Several studies have suggested that the low specificity
of TCD may be due to the fact that TCD is able to de-
tect both cardiac and pulmonary shunts [5]. The specifi-
city for a PFO shunt may be increased by a defined time
of micro bubble appearance. The passage time from the
antecubital vein injection site to the middle cerebral ar-
tery (MCA) through an intracardiac shunt is about
11 seconds, and it is about 14 seconds in the case of pul-
monary passage. The overlap interval between intrapul-
monary and cardiac passage level must be taken into
account [33].
In our study only in 4.8% of patients TEE did not show
the passage of contrast which was later detected by
TCD. The meaning of a shunt detected only during
TCD is not clearly understood, but a very small intracar-
diac shunt, not detected by TEE, cannot be excluded.
Furthermore the Valsalva maneuver may be less effective
during TEE than during TCD, because of esophageal
intubation. It is crucial to perform the Valsalva maneu-
ver properly. Contrary to other investigators, in our
material, the patients had been trained in performing
the Valsalva maneuver before study.
Recent studies as well as our results (95% sensitivity,
and 92% specificity of TCD), show a good concordance
between TCD and TEE with sensitivity ranging from
70% to 100% and specificity >95% [27,31,32].
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shunt detection [33].
Taking into account that TCD and TEE have similar
sensitivity and specificity in shunt detection TCD should
be recommended as the first choice for screening be-
cause of its low cost, and high feasibility. TCD is also a
noninvasive exam - easy to perform and repeat, if neces-
sary. TEE should be limited to the patients scheduled for
transcatheter PFO closure, patients with high-risk PFO
with recurrent stroke, and patients with ASA or large
shunt detected on TCD.
Conclusion
TCD has a relatively good sensitivity and specificity.
TCD and TEE are complementary for PFO diagnosis,
but TCD should be recommended as the first choice for
screening because of its simplicity, non-invasive charac-
ter, low cost, and high feasibility.
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